首页 | 期刊导航 | 学习空间 | 退出

期刊文章列表

  • Hengmin Xu,Wenqing Li(Key Laboratory of Carcinogenesis;Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital and Institute).Early detection of gastric cancer in China:progress and opportunities[J].Cancer Biology & Medicine,2022,第12期
  • Rilan Bai,Wenqian Li,Jiuwei Cui(Cancer Center, the First Hospital of Jilin University).Potential new applications of immunotherapy for neuroendocrine neoplasms:immune landscape, current status and future perspectives[J].Cancer Biology & Medicine,2022,第12期
  • Zhao Bi,Pengfei Qiu,Zhaopeng Zhang,Yongsheng Wang(Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University;Shandong Academy of Medical Sciences).Inconsistent radiotherapy effects between primary tumors and axillary lymph nodes[J].Cancer Biology & Medicine,2022,第12期
  • Song Chen1,Qingyu Zhang1,Lisha Lu1,Chunhui Xu1,Jiajia Li1,Jiali Zha2,Fengxia Ma1,Hongbo R.Luo2,3,4,Alan Y.Hsu2,3,4(State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology&Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College;Department of Pathology, Harvard Medical School, Boston;Department of Laboratory Medicine, The Stem Cell Program, Boston Children’s Hospital;Dana-Farber/Harvard Cancer Center).Heterogeneity of neutrophils in cancer:one size does not fit all[J].Cancer Biology & Medicine,2022,第12期
  • Xinxin Xu1,2,Yang Li1,2,Guoxiao Liu1,2,Kai Li1,2,Peng Chen,Yunhe Gao2,Wenquan Liang2,Hongqing Xi2,Xinxin Wang2,Bo Wei2,Hongtao Li,Lin Chen2(Medical School of Chinese PLA;Senior Department of General Surgery, The First Medical Center,Chinese PLA General Hospital;Department of General Surgery, The 940th Hospital of Joint Logistics Support Force of People’s Liberation Army).MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2[J].Cancer Biology & Medicine,2022,第12期
  • Huizhi Sun,Jing Mo2,Runfen Cheng,Fan Li2,Yue Li2,Yuhong Guo,Yanlei Li2,Yanhui Zhang,Xiaoyu Bai2,Yalei Wang,Xueyi Dong2,Danfang Zhang2,Jihui Hao(Tianjin Medical University Cancer Institute&Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer;Department of Pathology, Tianjin Medical University).ENO1 expression and Erk phosphorylation in PDAC and their effects on tumor cell apoptosis in a hypoxic microenvironment[J].Cancer Biology & Medicine,2022,第11期
  • Xuechen Chen1,2,Jie Ding1,Hengjing Li1,2,Prudence R.Carr3,Michael Hoffmeister1,Hermann Brenner1,4,5(Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ);Medical Faculty Heidelberg, Heidelberg University;School of Public Health and Preventive Medicine, Monash University;German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ);Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)).The power of a healthy lifestyle for cancer prevention:the example of colorectal cancer[J].Cancer Biology & Medicine,2022,第11期
  • Tobias Boch1,2,3,Jens K?hler1,2,3,Melanie Janning1,2,3,Sonja Loges1,2,3(DKFZ-Hector Cancer Institute at the University Medical Center Mannheim;Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ);Department of Personalized Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University).Targeting the EGF receptor family in non-small cell lung cancer——increased complexity and future perspectives[J].Cancer Biology & Medicine,2022,第11期
  • Jannis Wi?feld1,2,Anke Werner1,2,Xin Yan1,2,3,Nora ten Bosch1,2,Guoliang Cui1,2,3(Helmholtz Institute for Translational Oncology (HI-TRON);T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ);Faculty of Biosciences, Heidelberg University).Metabolic regulation of immune responses to cancer[J].Cancer Biology & Medicine,2022,第11期
  • Xiangli Jiang1,2,Fabricio Loayza-Puch2(Department of Thoracic Oncology, Tianjin Medical University Cancer Institute&Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer;Translational Control and Metabolism, German Cancer Research Center (DKFZ)).Roles of eIF5A in the immunosurveillance of cellular senescence[J].Cancer Biology & Medicine,2022,第11期
  • Michael Baumann(German Cancer Research Center (DKFZ)).Optimizing the cancer research landscape for the benefit of patients and society:A strategic perspective of the German Cancer Research Center (DKFZ) and its partnerships with university medical centers[J].Cancer Biology & Medicine,2022,第11期
  • Felix T. Kurz,Heinz-Peter Schlemmer(Department of Radiology, German Cancer Research Center).Imaging in translational cancer research[J].Cancer Biology & Medicine,2022,第11期
  • Kenan Zhang1,Xing Liu2,Guanzhang Li1,3,Xin Chang4,Shouwei Li4,Jing Chen1,Zheng Zhao1,Jiguang Wang5,6,7,Tao Jiang1,3,Ruichao Chai1,2,5(Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University;Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University;Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University;Department of Neurosurgery, Beijing Sanbo Brain Hospital, Capital Medical University;Division of Life Science and State Key Laboratory of Molecular Neuroscience, Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology;Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park;HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute).Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017):a multicenter retrospective study from CGGA[J].Cancer Biology & Medicine,2022,第10期
  • Halle Ronk,Jared S. Rosenblum,Timothy Kung,Zhengping Zhuang(Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health).Targeting PP2A for cancer therapeutic modulation[J].Cancer Biology & Medicine,2022,第10期
  • Lingxiang Wu1,2,Ruichao Chai3,4,Zheng Zhao3,4,Qianghu Wang1,2,Tao Jiang3,4,5(Department of Bioinformatics, Nanjing Medical University;Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University;Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University;Chinese Glioma Genome Atlas Network (CGGA);Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University).Role of the tumor microenvironment in shaping IDH-wildtype glioma plasticity, and potential therapeutic strategies[J].Cancer Biology & Medicine,2022,第10期
  • Weiling Chen1,2,3,4,Guimei Wang4,5,Guojun Zhang1,2,3,4(Department of Breast-Thyroid-Surgery and Cancer Center, Xiang’An Hospital of Xiamen University, School of Medicine,Xiamen University;Fujian Key Laboratory of Precision Diagnosis and Treatment in Breast Cancer,Xiang’An Hospital of Xiamen University;Key Laboratory for Endocrine-Related Cancer Precision Medicine of Xiamen, Xiang’An Hospital of Xiamen University;Xiamen Research Center of Clinical Medicine in Breast&Thyroid Cancers, Xiang’An Hospital of Xiamen University;Department of Pathology, Xiang’An Hospital of Xiamen University).Insights into the transition of ductal carcinoma in situ to invasive ductal carcinoma:morphology, molecular portraits, and the tumor microenvironment[J].Cancer Biology & Medicine,2022,第10期
  • Xiuchao Wang,Junjin Wang,Xi Wei,Lihui Zhao,Bo Ni,Zekun Li,Chuntao Gao,Song Gao,Tiansuo Zhao,Jian Wang,Weidong Ma,Xiao Hu3,Jihui Hao(Department of Pancreatic Cancer;Department of Diagnostic and Therapeutic Ultrasonography, Tianjin Medical University Cancer Institute&Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy,Tianjin, Tianjin’s Clinical Research Center for Cancer;Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University).Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms[J].Cancer Biology & Medicine,2022,第10期
  • Zongchao Mo1,2,Junyi Xin1,Ruichao Chai1,3,Peter Y.M.Woo4,5,Danny T.M.Chan6,Jiguang Wang1,2,7,8(Division of Life Science and State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology;HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute;Department of Molecular Neuropathology, Beijing Neurosurgical Institute,Capital Medical University;Department of Neurosurgery, Kwong Wah Hospital;Hong Kong Neuro-Oncology Society;Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital;Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology;Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park).Epidemiological characteristics and genetic alterations in adult diffuse glioma in East Asian populations[J].Cancer Biology & Medicine,2022,第10期
  • Yanwei Liu1,2,Huiyuan Chen2,3,Guanzhang Li2,4,Jing Zhang1,2,Kun Yao5,Chenxing Wu6,Shouwei Li6,Xiaoguang Qiu1,2(Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University;National Clinical Research Center for Neurological Diseases;Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University;Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University;Department of NeuropathologyDepartment of Neuropathology;Department of Neurosurgery,Sanbo Brain Hospital, Capital Medical University).Radiotherapy delays malignant transformation and prolongs survival in patients with IDH-mutant gliomas[J].Cancer Biology & Medicine,2022,第10期
  • Jilong Yang,Yu Xu2,Yong Chen2,Tao Li3,Xiaowei Zhang4,Tu Hu2,Ruwei Xing,Yun Yang(Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute&Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer,Key Laboratory of Molecular Cancer Epidemiology;Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Fudan University;Department of Bone and Soft tissue Surgery,Zhejiang Cancer Hospital;Department of Gastrointestinal Medical Oncology, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University).Therapeutic perspectives for adult soft tissue sarcoma——updates from the 2022 ASCO annual meeting[J].Cancer Biology & Medicine,2022,第10期
  • Huanyu Zhao1,Ruoyu Dang1,Yipan Zhu1,Baijian Qu1,Yasra Sayyed1,Ying Wen1,Xicheng Liu2,Jianping Lin1,Luyuan Li1(State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy;Department of Physiology and Pathophysiology).Hub genes associated with immune cell infiltration in breast cancer, identified through bioinformatic analyses of multiple datasets[J].癌症生物学与医学(英文版),2022,第9期
  • Shanshan He;Bowen Ding;Gang Li2;Yubei Huang;Chunyong Han;Jingyan Sun;Qingfeng Huang;Jing Liu;Zhuming Yin;Shu Wang;Jian Yin(Department of Breast Reconstruction, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University,Ministry of Education, Sino-Russian Joint Research Center for Oncoplastic Breast Surgery, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin’s Clinical Research Center for Cancer;School of Pharmacy, University College London;Department of Cancer Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute & Hospital,National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy,Tianjin, Tianjin’s Clinical Research Center for Cancer;Department of Breast Reconstruction, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University,Ministry of Education, Sino-Russian Joint Research Center for Oncoplastic Breast Surgery, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy,Tianjin, Tianjin’s Clinical Research Center for Cancer).Comparison of outcomes between immediate implant-based and autologous reconstruction:15-year, single-center experience in a propensity score-matched Chinese cohort[J].癌症生物学与医学(英文版),2022,第9期
  • Xu Zhang1,Na Qin1,2,Jingyi Fan3,Chang Zhang1,Qi Sun1,Yayun Gu1,2,Meng Zhu1,2,Erbao Zhang1,2,Juncheng Dai1,2,Guangfu Jin1,2,Hongxia Ma1,2,4,Zhibin Hu1,2,Hongbing Shen1,2,4(Department of Epidemiology;Jiangsu Key Lab of Cancer Biomarkers;Health Management Center;Research Units of Cohort Study on Cardiovascular Diseases and Cancers).A causal variant rs3769823 in 2q33.1 involved in apoptosis pathway leading to a decreased risk of non-small cell lung cancer[J].癌症生物学与医学(英文版),2022,第9期
  • Yubei Huang;Huan Wang;Zhangyan Lyu;Hongji Dai;Peifang Liu;Ying Zhu;Fengju Song;Kexin Chen(Department of Cancer Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Molecular Epidemiology of Tianjin, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education;Department of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Molecular Epidemiology of Tianjin, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education).Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer[J].癌症生物学与医学(英文版),2022,第9期
  • Xiaoyu Gao1,2,Qingqing Feng1,Jing Wang3,Xiao Zhao1,2,4(CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety&CAS Center for Excellence in Nanoscience;University of Chinese Academy of Sciences;Center of Drug Evaluation;IGDB-NCNST Joint Research Center).Bacterial outer membrane vesicle-based cancer nanovaccines[J].癌症生物学与医学(英文版),2022,第9期
  • Ying Liu,Meng Wang,Ting Deng,Rui Liu,Tao Ning,Ming Bai,Guoguang Ying,Haiyang Zhang,Yi Ba(Tianjin Medical University Cancer Institute and Hospital).Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C/EPBβ[J].癌症生物学与医学(英文版),2022,第9期
  • Huan Xu1,2;Junyi Chen3;Zhi Cao1;Xi Chen1,4;Caihong Huang5;Jin Ji1;Yalong Xu1;Junfeng Jiang6;Yue Wang6;Guowang Xu7;Lina Zhou7;Jingyi He8;Xuedong Wei8;Jason Boyang Wu9;Zhong Wang2;Shancheng Ren1;Fubo Wang5(Department of Urology, Shanghai Changhai Hospital, Second Military Medical University;Department of Urology, Shanghai Ninth People's Hospital;Department of Urology, the Second Affiliated Hospital of Fujian Medical University;Department of Urology, No. 971 Hospital of the People's Liberation Army Navy;Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University;Research Center of Developmental Biology, Second Military Medical University;Dalian Institute of Chemical Physics, Chinese Academy of Sciences;Department of Urology, the First Affiliated Hospital of Soochow University;Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University;Department of Urology, Shanghai Ninth People’s Hospital).Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy[J].癌症生物学与医学(英文版),2022,第9期
  • Huan Liu1,2,3,Ronghua Zhao1,Rongrong Qin1,Haoyu Sun2,3,Qiang Huang1,Lianxin Liu1,Zhigang Tian2,3,Bj?rn Nashan1,Cheng Sun1,2,3,Rui Sun2,3(The First Affiliated Hospital of USTC;The CAS Key Laboratory of Innate Immunity and Chronic Disease;Institute of Immunology).Panoramic comparison between NK cells in healthy and cancerous liver through single-cell RNA sequencing[J].癌症生物学与医学(英文版),2022,第9期
  • Haoran Mu1,Dongqing Zuo1,Jie Chen2,Zhigang Liu3,Zhuo Wang3,Liu Yang1,Qihui Shi3,4,5,Yingqi Hua1(Shanghai Bone Tumor Institute and Department of Orthopedics;Key Laboratory of Systems Biomedicine(Ministry of Education);Shanghai Key Laboratory of Medical Epigenetics and the International Co-laboratory of Medical Epigenetics and Metabolism(MOST);Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer(SMHC)and Institute of Fudan-Minhang Academic Health System;Shanghai Engineering Research Center of Biomedical Analysis Reagents).Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis[J].癌症生物学与医学(英文版),2022,第9期
  • Lidong Wang1,2,Zhihua Liu2,3(Research Integrity Construction Office(RICO);The Supervisory Committee;State Key Laboratory of Molecular Oncology).Reflections on the withdrawal of medical articles and the development of writing and publishing standards[J].癌症生物学与医学(英文版),2022,第9期
首页 1 2 3 4 5 下一页 尾页 共有5页,转到 页

帮助 | 繁體中文 | 关于发现 | 联系我们

超星发现系统 Copyright©·powered by 超星

客服电话:4008236966